Cefazolin Injection, Powder, For Solution
Product Images NDC 44567-707

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefazolin (NDC 44567-707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefazolin Structural Formula (Image 01)

Chemical structure of Cefazolin as shown in the image, depicting the molecular arrangement with rings, sulfur atoms, and sodium component.*

FDA Label Image

Cefazolin 500 mg Vial Label (Image 02)

Cefazolin 500 mg injection powder vial label for solution, intended for intravenous or intramuscular use. Contains 500 mg of cefazolin sodium per vial. The label includes dosage instructions, storage conditions, and the labeler WG Critical Care, LLC. The product is sterile, nonpyrogenic, preservative-free, and made in Italy.*

FDA Label Image

Cefazolin 1 Gram Vial Label (Image 03)

Label for Cefazolin injection powder, USP, 1 gram per vial, intended for intravenous or intramuscular use. The vial contains cefazolin sodium equivalent to 1 gram of cefazolin. The label states the product is sterile, nonpyrogenic, preservative free, with storage and reconstitution instructions. Manufactured by WG Critical Care, LLC, Paramus, NJ, made in Italy.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.